ZENITH LABS &lt;ZEN> REPORT 4TH QTR LOSS Zenith Laboratories company report fourth quarter loss, amount determined completion year end audit. company elaborate further. quarter ended Sept 30, 1986, Zenith reported loss 3,451,000 dlrs 16 cts share, adjusted 1986 2-for-1 stock split. company received Food Drug Administration approval market Cefadroxil, generic version antibiotic domestic sales exceeding 50 mln dlrs 1986. Zenith market drug "questions relating applicability patents resolved."